Call for Abstract

2nd International Conference on Mycology & Mushrooms, will be organized around the theme “Impact of Mycology and Mushrooms in addressing ultimate global health challenges”

Mycology 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Mycology 2017

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Medical mycology is the study of fungal infections. In immune-compromised hosts systemic fungal infections are usually seen. Systemic fungal infections lead to pulmonary infections. Fungal infections are usually seen on skin, nails, and hair. Common fungal infections are intertrigo, thrush, and pityriasis versicolor, athlete’s foot, nail infections, ring worm of the body, ring worm of the groin.

  • Track 1-1Fungal pathogens
  • Track 1-2Fungal infections
  • Track 1-3Fungi associated with human and animal disease
  • Track 1-4Epidemiology and public health mycology
  • Track 1-5Pharmacology and antifungal susceptibilities
  • Track 1-6Vaccines for prevention of fungal infections
  • Track 1-7Molecular biology of pathogenic fungi

The mushroom is a spore-bearing, fleshy fruiting body of a fungus, which grows above ground on soil or on organic food source. The most important microscopic feature for identification of mushrooms is the spores. Their spores, called basidiospores, are produced on the gills and fall in a fine rain of powder from under the caps as a result. Mushrooms are the fruit bodies of members of the order agaricales, whose type genus is agaricus and type species is the field mushroom, agaricus campestris. However, in modern molecularly defined classifications, not all members of the order agaricales produce mushroom fruit bodies, and many other gilled fungi, collectively called mushrooms, occur in other orders of the class agaricomycetes. It is formed within the mycelium, the mass of threadlike hyphae that make up the fungus. Many species of mushrooms seemingly appear overnight, growing or expanding rapidly. In reality all species of mushrooms take several days to form primordial mushroom fruit bodies, though they do expand rapidly by the absorption of fluids. An atypical mushroom is the lobster mushroom, which is a deformed, by the mycoparasitic ascomycete hypomyces lactifluorum. Some are having pores underneath, others have spines. 


  • Track 2-1Identification
  • Track 2-2Classification
  • Track 2-3Etymology
  • Track 2-4Morphology
  • Track 2-5Edible and toxic mushrooms
  • Track 2-6Medicinal mushrooms
  • Track 2-7Psychoactive mushrooms
  • Track 2-8Mushroom production technology

Fungal biofilms are a growing clinical problem related with significant rates of mortality. Candida albicans is the most notorious of all fungal biofilm formers. However, non-Candida species, yeasts such as Cryptococcus neoformans, and filamentous moulds such as Aspergillus fumigatus, have been shown to be implicated in biofilm-associated infections. Fungal biofilms have distinct developmental phases, including adhesion, colonisation, maturation and dispersal, which are governed by complex molecular events. Recalcitrance to antifungal therapy remains the greatest threat to patients with fungal biofilms. This analysis is to discuss our current understanding of the basic biology and clinical implications associated with fungal biofilms.

  • Track 3-1Fungal pathogen biofilm architecture
  • Track 3-2Genetic determinants of fungal biofilm formation
  • Track 3-3Gene expression portrait of fungal biofilms
  • Track 3-4Mating type and fungal biofilms
An antifungal medication is a pharmaceutical fungicide or fungi static used to treat and prevent mycoses, which are most commonly found on the skin, hair and nails. It works by exploiting differences between mammalian and fungal cells to kill the fungal organism with fewer adverse effects to the host.  Antifungal medicines are used in several ways, depending on your specific fungal infection. The main types of antifungal medicines includes, topical antifungals, oral antifungals, intravenous antifungals, intravaginal antifungal pessaries etc.
  • Track 4-1Polyene anti fungals
  • Track 4-2Imidazole, triazole, and thiazole antifungals
  • Track 4-3Allylamines
  • Track 4-4Echinocandins

Most industrial processes used fungal cells for the bulk manufacturing of organic acids, proteins, enzymes, secondary metabolites and active pharmaceutical ingredients in white and red biotechnology. A number of challenges now need to be addressed to improve our strategies to control fungal pathogenicity and to optimise the use of fungi as sources for novel compounds. In addition to the multiple reaction sequences of fermentations, fungi are extremely useful in carrying out biotransformation processes. Molecular manipulations have been added to mutational techniques as a means of increasing yields of microbial processes and in the discovery of new drugs. 

  • Track 5-1Marine mycotechnology
  • Track 5-2Fungal metabolites
  • Track 5-3Genetic engineering of filamentous fungi
  • Track 5-4Fungal leaching
  • Track 5-5Fungal use in control of pests and pathogens
  • Track 5-6Yeast and synthetic biology

Fungi are eukaryotic organisms which cannot produce their own energy and depend on enzymatic processes for metabolic activity to absorb nutrition. Its kingdom encompasses tremendous biological diversity, with members covering a wide range of lifestyles, forms, habitats, and sizes. Advances in molecular techniques have formed the base for a boost in studies concerning fungal diversity and the fast development of next generation sequencing technologies promises further progress towards a more thorough understanding of fungal diversity and function. The current limited knowledge of fungal diversity and biology complicates an assessment of the conservation status of fungal species and has hindered the development of conservation tools and efforts. 

  • Track 6-1Fungal classification
  • Track 6-2Biodiversity, and systematic
  • Track 6-3Marine fungi
  • Track 6-4Molecular phylogeny
  • Track 6-5The genomic revolution

Pathogenic fungi cause disease in humans and in other organisms, which is called as fungal pathogenesis. Fungal pathogens can be divided into two general classes’ primary pathogens and opportunistic pathogens. Currently, there has been a dramatic increase in fungal infections of this type, in particular candidiasis, cryptococcosis, aspergillosis, and zygomycosis. More recently described mycoses of this category include hyalohyphomycosis and phaeohyphomycosis.

The superficial mycoses -these are superficial cosmetic fungal infections of the skin or hair shaft.

Dermatophytosis - ringworm or tinea - ringworm of scalp, glabrous skin, and nails caused by a closely related group of fungi known as dermatophytes.

The subcutaneous mycoses - these are chronic, localized infections of the skin and subcutaneous tissue following the traumatic implantation of the aetiologic agent.

Infectious disease mycology - these are fungal infections of the body caused by dimorphic fungal pathogens.

  • Track 7-1Dermatophytosis
  • Track 7-2Chromoblastomycosis
  • Track 7-3Sporotrichosis
  • Track 7-4Phaeohyphomycosis
  • Track 7-5Hyalohyphomycosis
  • Track 7-6Aspergillosis
  • Track 7-7Zygomycosis (mucormycosis)
  • Track 7-8Cryptococcosis
  • Track 7-9Candidiasis
  • Track 7-10Coccidioidomycosis
  • Track 7-11Histoplasmosis
  • Track 7-12Mycetoma

Mushrooms play extremely important roles in the ecosystem, and some are famously delicious, but some are also famously deadly. In recent years has focused on various immunological and anti-cancer properties of certain mushrooms, they also offer other potentially important health benefits, including antioxidants, anti-hypertensive and cholesterol-lowering properties, liver protection, as well as anti-inflammatory, anti-diabetic, anti-viral and anti-microbial properties. These properties have attracted the interest of many pharmaceutical companies, which are viewing the medicinal mushroom as a rich source of innovative biomedical molecules. 

  • Track 8-1Reishi (Ganoderma lucidum)
  • Track 8-2Mitake (Grifola frondosa)
  • Track 8-3Agarikon (Laricifomes officinalis)
  • Track 8-4Coliolus (Trametes versicolor)
  • Track 8-5Selenium (an important antioxidant)
  • Track 8-6Protein
  • Track 8-7Shitake (Lentinula edodes)

Bacterial and fungal interactions can form a range of physical associations that depend on various modes of molecular communication for their development and functioning. The combination of physical associations and molecular interactions between fungi and other microbes can result in a variety of different outcomes for each partner. In turn, these changes may affect the influence of the fungal-microbe  complex. Applications are found in various biological fields i.e. Food processing, fermentation and brewing, cheese ripening, bioremediation of pollutants, natural product discovery and synthetic biology

  • Track 9-1Physical complexes between bacteria and fungi
  • Track 9-2Molecular interactions
  • Track 9-3Consequences of bacterial-fungal interactions
  • Track 9-4Applications of bacterial-fungal interactions
  • Track 9-5Effects on environment, food, and medicine
  • Track 9-6Medically important bacterial-fungal interactions
  • Track 9-7Pathogens to mutualistic endosymbiosis

Mycotoxins are the secondary metabolites that are produced by filamentous fungi. It is capable of causing disease and death in humans and other animals. Because of their pharmacological activity, some mycotoxins or mycotoxin derivatives have found use as antibiotics, growth promotants, and other kinds of drugs; still others have been implicated as chemical warfare agents. Mycoses are the best-known diseases of fungal etiology, but toxic secondary metabolites produced by saprophytic species are also an important health hazard. The term mycotoxin is an artificial rubric used to describe pharmacologically active mold metabolites characterized by vertebrate toxicity. Mycotoxins generally enter the body via ingestion of contaminated foods, but inhalation of toxigenic spores and direct dermal contact are also important routes.

  • Track 10-1Mycoses and mycotoxicoses
  • Track 10-2Trichothecenes
  • Track 10-3Patulin
  • Track 10-4Ochratoxin
  • Track 10-5Fumonisins
  • Track 10-6Ergot alkaloids
  • Track 10-7Citrinin
  • Track 10-8Aflatoxins
  • Track 10-9Toxicology and human health
  • Track 10-10Definitions, etymology, and general principles
  • Track 10-11Zearalenone

Filamentous fungi are used by industry for manufacture of a large variety of useful products. The products include metabolites, enzymes and food. Fungal cells can grow at different environmental conditions and environmental diversity. The chemical and physical conditions used for fungal propagation which depends up on fungal genetics and biology will have a great impact on the capability of these cells to accumulate the desired product(s). Mevinolin, cyclosporine A, β-lactam antibiotics, pneumocandins, ergotamine, strobilurins, and mycophenolic acid are examples of revolutionary pharmaceuticals and agrochemicals that have a fungal origin in spite of the success of bioactive fungal metabolites as pharmaceuticals and agrochemicals and fungi remain s an essentially untapped source of medicines because only a small fraction of the vast fungal kingdom has been explored for bioactive metabolite production. However, recent advances in the genetics of microbial secondary metabolite biosynthesis, genomics, and metabolic engineering will play an ever-increasing role in facilitating fungal bioactive metabolites discovery.

  • Track 11-1Food and Beverages Industry
  • Track 11-2Baking Industry
  • Track 11-3Mycoprotein – Quorn
  • Track 11-4Antibiotics – Penicillin
  • Track 11-5Immuno-suppressive
  • Track 11-6Vitamins
  • Track 11-7Mycodiesel
  • Track 11-8Fungi in waste treatment

Fungi occur in all type of environment on earth and plays vital roles in most ecosystems. These are the major decomposers along with bacteria in most terrestrial and some aquatic ecosystems, and therefore play a critical role in biogeochemical cycles and in many food webs play an essential role in nutrient cycling by degrading organic matters to inorganic molecules, which can then re-enter to different anabolic metabolic pathways in plants and other organisms. 

  • Track 12-1Population dynamics, adaptation and evolution
  • Track 12-2Role in ecosystem functioning
  • Track 12-3Nutrient cycling, decomposition and carbon allocation
  • Track 12-4Eco-physiology
  • Track 12-5Intra- and inter-specific mycelial interactions
  • Track 12-6Fungus-plant (pathogens, mycorrhizas, lichens, endophytes)
  • Track 12-7Fungus-invertebrate and fungus-microbe interaction
  • Track 12-8Genomics and (evolutionary) genetics
  • Track 12-9Bioremediation and biodegradation

Symbioses are the type of intimate associations which involves two or more species. Fungi have numerous symbioses involving many eukaryotes and prokaryotes. Symbioses are categorized according to the relative benefit or harm that the partners experience as a consequence of the interactions i.e. Parasitism or mutualism in the association.

Lichen - The appearance of lichens is plant-like which hides their true identity. It is not a single organism, but the result is mutualistic symbiosis between an alga or cyanobacteria and a fungus. The fungus lichen provides its partner a benefit by giving protection and in return it gains nutrients. Lichens can grow in a wide range of shapes and is usually determined according to the organization of the fungal filaments. The fungus part of lichen benefits from the algae or cyanobacteria as they produce food by photosynthesis. 

Mycorrhizae – This association is between fungi and plant roots, where the fungi derive photosynthetic sugars from the plants, and they assist the plant by facilitating the uptake of mineral nutrients and water. Approximately 70-80% of all plants have mycorrhizae. There are two major forms of mycorrhizae.

  • Ectomycorrhizae are formed primarily by basidiomycetes and also a few ascomycetes. 
  • Arbuscular mycorrhizae are formed by zygomycetes called glomales
  • Track 13-1Mutualist dynamics
  • Track 13-2Cyanolichens
  • Track 13-3Occurrence of mycorrhizal associations
  • Track 13-4Types of mycorrhizas

The presence of fungi in food has been both advantage and problems to food stores. Fungi can spoil large quantities of food and produce dangerous toxins that threaten human health; however, fungal spoilage in certain foods can produce a unique, highly prized food source and there are some very effective fungal derived medicines. A thorough understanding of the vast body of knowledge relating to food mycology requires an inclusive volume that covers both the beneficial and detrimental roles of fungi in our food supply. These include food groups such as bakery products, dairy products, beverages (e.g. fruit juices), dried fruits and nuts, and confectionary. Fungi can also present health risks by the production of specific toxic agents called mycotoxins, which are often poorly understood, but are being increasingly recognised as agents of both acute and chronic toxicity in humans and animals. This creates an opportunity in research towards the fungi and yeasts, and the problems they can cause in foods, in terms of spoilage and health effects. It will present a balanced view of the importance of these agents in the context of the modern food industry.

  • Track 14-1Impact of Climate changes on Food security and Food safety
  • Track 14-2Mycotoxin production in foods
  • Track 14-3Predictive models for fungal growth
  • Track 14-4Techniques for detection and eradication of fungi
  • Track 14-5Food ecology and the association of certain fungal species with specific food products
  • Track 14-6Standardise methods for isolation, enumeration and identification of fungi in foods

A key ingredient in successful entrepreneurship is self-knowledge. (Mycology-2016) aims to bring together all existing and budding bio entrepreneurs to share experiences and present new innovations and challenges in microbiological community. Each year, over a million companies are started in the world with about 5–10 of them classified as high technology companies. Turning ideas into business ventures is tricky and the opportunity-recognition step is critical in new venture creation. This gestalt in the entrepreneur's perception of the relationship between the invention and final product is refined into a business model that describes how the venture will make money or provide an appropriate return to the potential investors. Biological science is complex and rapidly changing and requires a specialized knowledge to understand the value of the innovation and its competitive position in the industry. Although life scientists are typically the founders of biotech companies, studies have shown that the most successful high tech startups are founded by a team of two to three individuals with mixed backgrounds, substantial industry experience and a very clear market and product focus at founding. This three day community-wide conference will be a highly interactive forum that will bring experts in areas ranging from structural microbiology to signaling pathways to novel therapeutic approaches to the scientific hub. In addition to our outstanding speakers, we will also showcase short talks and poster presentations from submitted abstracts.The speakers will discuss how microbes can be engineered to report using computational inputs from their local environment. This session will include combined efforts of cutting edge synthetic biology research to highlight the current state, challenges and future of engineered microbial communities.